PhD, Neuropharmacology, University of Illinois Health Sciences Center (1985)
MD, Nuclear Medicine, University of Illinois Health Sciences Center (1981)
BS, General Science and Sociology, University of Iowa (1976)
Employment:
Medical Director, Nuclear Medicine Technology Program, University at Buffalo (2010-present)
Program Director, Nuclear Medicine Residency Program, University at Buffalo (2010-present)
CME Program Director, Department of Nuclear Medicine, University at Buffalo (2008-present)
Professor, Nuclear Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2006-present)
Associate Professor, Nuclear Medicine, University at Buffalo Jacobs School of Medicine & Biomedical Sciences (2004–2006)
Associate Professor, Department of Neurology, University at Buffalo School of Medicine and Biomedical Sciences (2004–2006)
Awards and Honors:
Outstanding Accreditation Award, Nuclear Medicine Residency (2011)
Collimator Award for teaching excellence (1998,2000,2008) (2008)
Fellow of the American Association for the Advancement of Science (1991)
Medical Scientist Scholarship (1985)
Alpha Omega Alpha Honor Medical Society (1980)
Phi Beta Kappa Honor Society (1975)
Research Expertise:
Editorial Consultant: Archives of Neurology. Journal of Neuroimaging. Journal of Computed Assisted Tomography. Neuropharmacology. Pharmacopeial Forum
Grants and Sponsored Research:
January 2013–December 2017 Advancing Schizophrenia Treatment Breakthroughs, Education and Outreach in Western New York Patrick E. Lee Foundation Role: Co-Investigator $660,000
Hartley-McAndrew ME, Miletich RS, Farooq O. (2019) In: "Nuclear neurology of autism spectrum disorder". IOP Publishing Ltd., 6-1-6-13.
Abstracts:
Miletich RS, Boudreau M, Li P, Li V. (2013) Ictal SPECT Activation in a Case of Gelastic Seizures Caused by a Low Grade Glioma in the Posteriolateral Temporal Lobe. Epilepsia, (Dec)
Miletich RS, Wack DS. (2013) Alzheimer-like global brain impairment in newly diagnosed lung cancer. Society for Neuroscience, (Jan)
Jaisani Z, Ramanathan M, Miletich R, Weinstock A. (2011) The Yield of FDG-PET in Patients with Temporal Lobe Epilepsy and Post Surgical Outcome. (Dec)
Farooq O, Lincoff NS, Saikali, N, Prasad D, Miletich RS, Mechtler L. (2011) Novel Treatment for Radiation Optic Neuropathy with IV Bevacizumab. University of Buffalo 14th Annual Spring Clinical Research Day, (May)
Farooq O, Lincoff NS, Saikali N, Prasad D, Miletich RS, Mechtler L. (2011) Novel Treatment for Radiation Optic Neuropathy with IV Bevacizumab. American Academy of Neurology, (Apr)
Farooq O, Lincoff NS, Saikali N, Prasad D, Miletich RS, Mechtler L. (2011) Novel Treatment for Radiation Optic Neuropathy with IV Bevacizumab. North American Neuro-Ophthalmology Society, (Feb)
Professional Memberships:
Organization for Human Brain Mapping (2003–present)
Academy for Molecular Imaging (2002–present)
Society of Nuclear Imaging in Drug Development (1999–2002)
International Society for Cerebral Blood Flow and Metabolism, (1996–present)
The Movement Disorder Society (1996–present)
World Federation of Neurology (1995–present)
American Society of Neuroimaging (1995–present)
Institute for Clinical PET (1994–2002)
Buffalo-Rochester-Syracuse Neuro-Oncology Research Group (1994–2000)
Society of Nuclear Medicine; Brain Imaging Council (1990–present)
International Brain Research Organization (1989–present)
World Federation of Neuroscience (1989–present)
New York Academy of Science (1988–present)
American Association for the Advancement of Science (1986–present)
American Academy of Neurology; Section on Neuroimaging Section on Movement Disorders (1983–present)
Alpha Omega Alpha Honor Medical Society (1980–present)